Determining Spectroscopic Quantitation Limits for Misfolded Structures
نویسندگان
چکیده
منابع مشابه
Determining quantitation levels for regulatory purposes
ecently, water regulatory agencies and providers have shown considerable interest in determining the lowest quantifiable level that is suitable for regulatory purposes.1–8 Allowable concentration levels for a contaminant in a particular environmental medium (e.g., soil, air, or water) are often based on health-related risk assessments and are sometimes lower than levels that can be quantitated ...
متن کاملA New Algorithm for Determining Ultimate Pit Limits Based on Network Optimization
One of the main concerns of the mining industry is to determine ultimate pit limits. Final pit is a collection of blocks, which can be removed with maximum profit while following restrictions on the slope of the mine’s walls. The size, location and final shape of an open-pit are very important in designing the location of waste dumps, stockpiles, processing plants, access roads and other surfac...
متن کاملSetting Meaningful Detection and Quantitation Limits for Chromatography Methods
When reporting or using results of quantitative analysis, it is important to understand the uncertainties associated with the reported values. Every method, no matter how good, has limitations that create some degree of measurement error, which can be manifested as inaccuracy, imprecision, or a combination of these. Relative measurement error tends to increase as analyte concentrations decrease...
متن کاملDetermining the Limits of Automated Program Recognition
Program recognition is a program understanding technique in which stereotypic computational structures are identified in a program. From this identification and the known relationships between the structures, a hierarchical description of the program's design is recovered. The feasibility of this technique for small programs has been shown by several researchers. However, it seems unlikely that...
متن کاملDetermining decision limits for new biomarkers: clinical and statistical considerations.
The pathway from discovery to clinical adoption of new biomarkers is marked by a series of significant benchmarksthatrelatively fewcardiovascularbiomarkers have successfully navigated (1 ). For those biomarkers that do emerge as viable candidates for clinical use, determining appropriate decision limits takes on substantial importance. In our experience, this task is demanding and is regularly ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pharmaceutical Sciences
سال: 2020
ISSN: 0022-3549
DOI: 10.1016/j.xphs.2019.09.004